Invesco Ltd. Purchases New Holdings in Stevanato Group S.p.A. $STVN

Key Points

• Invesco Ltd. invested approximately $19.07 million in Stevanato Group S.p.A. by acquiring 933,964 shares, increasing its stake to 0.31% as per the latest SEC filing.
• Several other large investors also adjusted their stakes in Stevanato Group, with notable increases from Wells Fargo (680.3%) and Tower Research Capital (202.8%) in the fourth quarter.
• Analysts have given Stevanato Group a largely positive outlook, with one analyst rating it as a Strong Buy and a cumulative average rating of "Moderate Buy."

Invesco Ltd. purchased a new stake in Stevanato Group S.p.A. (NYSE:STVN - Free Report) during the first quarter, according to its most recent filing with the SEC. The fund purchased 933,964 shares of the company's stock, valued at approximately $19,072,000. Invesco Ltd. owned about 0.31% of Stevanato Group as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Whittier Trust Co. bought a new stake in Stevanato Group in the 1st quarter valued at $27,000. Johnson Financial Group Inc. bought a new stake in Stevanato Group in the 4th quarter valued at $41,000. Van Berkom & Associates Inc. grew its stake in shares of Stevanato Group by 33.3% in the 1st quarter. Van Berkom & Associates Inc. now owns 2,400 shares of the company's stock worth $49,000 after buying an additional 600 shares in the last quarter. Wells Fargo & Company MN grew its stake in shares of Stevanato Group by 680.3% in the 4th quarter. Wells Fargo & Company MN now owns 3,246 shares of the company's stock worth $71,000 after buying an additional 2,830 shares in the last quarter. Finally, Tower Research Capital LLC TRC grew its stake in shares of Stevanato Group by 202.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 7,413 shares of the company's stock worth $162,000 after buying an additional 4,965 shares in the last quarter.

Analyst Upgrades and Downgrades

Separately, William Blair reissued an "outperform" rating on shares of Stevanato Group in a research note on Monday, June 30th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have given a Hold rating to the company. According to MarketBeat, Stevanato Group presently has an average rating of "Moderate Buy".

Stevanato Group Trading Up 3.2%

NYSE:STVN traded up €0.69 during mid-day trading on Wednesday, hitting €22.34. 281,000 shares of the stock traded hands, compared to its average volume of 337,053. The stock has a market capitalization of $6.77 billion, a price-to-earnings ratio of 41.37, a PEG ratio of 2.04 and a beta of 0.55. Stevanato Group S.p.A. has a 52 week low of €17.12 and a 52 week high of €28.00. The firm's 50 day moving average is €24.22 and its two-hundred day moving average is €22.49. The company has a quick ratio of 1.22, a current ratio of 1.79 and a debt-to-equity ratio of 0.25.

Stevanato Group Company Profile

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.